Literature DB >> 28374274

Bilateral extensive nodular xanthelasma palpebrarum: an infrequent case report.

Pei Wang1, Qingli Luo1, Li Tang2.   

Abstract

PURPOSE: To report a rare case of extensive bilateral xanthelasma palpebrarum (XP). A 70-year-old man presented with nodular lesions of his eyelids for 12 years. The skin changes began with his left lower eyelid and progressively spread to both lateral-inferior and infero-medial periorbital areas. The lesions were yellow nodules that were hard, extensive, multiple and coalescent.
METHOD: The tumors of this patient's eyelids underwent resection and tissue was processed for light microscopic examination. RESULT: Under light microscopy, many foamy xanthoma cells were found in the dermis, often nested around capillaries. Touton giant cell were also be observed, and tissue fibrous hyperplasia was obvious. The pathological changes were seen in the orbicularis oculi muscle, where many foamy xanthoma cells were seen between the muscle fibers.
CONCLUSION: XP is the most common cutaneous xanthoma and typically presents in the middle-aged and elderly. This presentation of XP is notable because of its extent. The light microscopic appearance confirmed the diagnosis of XP. Surgical intervention provided substantial cosmesis.

Entities:  

Keywords:  Eyelid; Hypercholesteremia; Surgery; Xanthelasma palpebrarum; Xanthoma

Mesh:

Year:  2017        PMID: 28374274     DOI: 10.1007/s10792-017-0506-6

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  10 in total

Review 1.  Xanthelasma palpebrarum: a review and current management principles.

Authors:  Rod J Rohrich; Jeffrey E Janis; Patrick H Pownell
Journal:  Plast Reconstr Surg       Date:  2002-10       Impact factor: 4.730

2.  Extensive bilateral eyelid ptosis caused by xanthoma palpebrarum.

Authors:  E Ustünsoy; Z Demir; K Coşkunfírat; A Kurtay; A Aksoylar; Y Türkgüven
Journal:  Ann Plast Surg       Date:  1997-02       Impact factor: 1.539

3.  Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi.

Authors:  A Jain; P Goyal; P K Nigam; H Gurbaksh; R C Sharma
Journal:  Indian J Clin Biochem       Date:  2007-09

4.  Pathologic quiz case 1. Xanthelasma palpebrarum.

Authors:  W E Hagan; J K Duplechain; M Cheney
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1986-09

Review 5.  Xanthomas: clinical and pathophysiological relations.

Authors:  Ales Zak; Miroslav Zeman; Adolf Slaby; Marek Vecka
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2014-04-29       Impact factor: 1.245

6.  Periorbital Hyperpigmentation in Patients with Xanthelasma Palpebrarum: An Interesting Observation.

Authors:  Eftychia Platsidaki; Anargyros Kouris; Efthymia Agiasofitou; Christina Antoniou; Georgios Kontochristopoulos
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01

7.  Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.

Authors:  Hossein Kavoussi; Ali Ebrahimi; Mansour Rezaei; Mazaher Ramezani; Behnaz Najafi; Reza Kavoussi
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

Review 8.  Adult orbital xanthogranulomatous disease: review of the literature.

Authors:  Jin Guo; Jun Wang
Journal:  Arch Pathol Lab Med       Date:  2009-12       Impact factor: 5.534

9.  Bilateral and extensive xanthelasma palpebrarum in a young man.

Authors:  M J Depot; F A Jakobiec; J M Dodick; T Iwamoto
Journal:  Ophthalmology       Date:  1984-05       Impact factor: 12.079

Review 10.  The pathogenesis and clinical significance of xanthelasma palpebrarum.

Authors:  R Bergman
Journal:  J Am Acad Dermatol       Date:  1994-02       Impact factor: 11.527

  10 in total
  1 in total

1.  The Significance of Extracellular Cholesterol Crystals or a Cholesterol Granuloma in Xanthelasma.

Authors:  Frederick A Jakobiec; Lina Ma; Natalie Wolkow; Francis C Sutula; Suzanne K Freitag
Journal:  Ocul Oncol Pathol       Date:  2018-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.